Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02740166Phase 4Unknown
Phase 4, randomised, open-label trial of propranolol in esophageal varices, sponsored by Kaohsiung Veterans General Hospital. Primary endpoints: Recurrent esophageal variceal bleeding at 6 years and Mortality or liver transplantation at 6 years. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02740166.